U.S. flag

An official website of the United States government

NM_000322.5(PRPH2):c.537G>T (p.Trp179Cys) AND PRPH2-related disorder

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Oct 18, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001213611.5

Allele description [Variation Report for NM_000322.5(PRPH2):c.537G>T (p.Trp179Cys)]

NM_000322.5(PRPH2):c.537G>T (p.Trp179Cys)

Gene:
PRPH2:peripherin 2 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
6p21.1
Genomic location:
Preferred name:
NM_000322.5(PRPH2):c.537G>T (p.Trp179Cys)
HGVS:
  • NC_000006.12:g.42721798C>A
  • NG_009176.2:g.5823G>T
  • NM_000322.5:c.537G>TMANE SELECT
  • NP_000313.2:p.Trp179Cys
  • NC_000006.11:g.42689536C>A
  • NG_009176.1:g.5823G>T
  • NM_000322.4:c.537G>T
Protein change:
W179C
Links:
dbSNP: rs779414078
NCBI 1000 Genomes Browser:
rs779414078
Molecular consequence:
  • NM_000322.5:c.537G>T - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
PRPH2-related disorder
Synonyms:
PRPH2-Related Disorders; PRPH2-related condition
Identifiers:
MedGen: CN239395

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001385248Invitae
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Pathogenic
(Oct 18, 2023)
germlineclinical testing

PubMed (4)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Copy-number variation contributes 9% of pathogenicity in the inherited retinal degenerations.

Zampaglione E, Kinde B, Place EM, Navarro-Gomez D, Maher M, Jamshidi F, Nassiri S, Mazzone JA, Finn C, Schlegel D, Comander J, Pierce EA, Bujakowska KM.

Genet Med. 2020 Jun;22(6):1079-1087. doi: 10.1038/s41436-020-0759-8. Epub 2020 Feb 10.

PubMed [citation]
PMID:
32037395
PMCID:
PMC7272325

Genotype-phenotype associations in a large PRPH2-related retinopathy cohort.

Reeves MJ, Goetz KE, Guan B, Ullah E, Blain D, Zein WM, Tumminia SJ, Hufnagel RB.

Hum Mutat. 2020 Sep;41(9):1528-1539. doi: 10.1002/humu.24065. Epub 2020 Jul 5.

PubMed [citation]
PMID:
32531846
PMCID:
PMC7484419
See all PubMed Citations (4)

Details of each submission

From Invitae, SCV001385248.5

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (4)

Description

This sequence change replaces tryptophan, which is neutral and slightly polar, with cysteine, which is neutral and slightly polar, at codon 179 of the PRPH2 protein (p.Trp179Cys). This variant is present in population databases (rs779414078, gnomAD 0.004%). This missense change has been observed in individuals with retinitis pigmentosa (PMID: 32037395, 32531846; Invitae). ClinVar contains an entry for this variant (Variation ID: 866955). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt PRPH2 protein function. This variant disrupts the p.Trp179 amino acid residue in PRPH2. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 10862101). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Jun 23, 2024